Chronic necrotizing pulmonary aspergillosis after SARS-Cov-2 infection – a case report
DOI:
https://doi.org/10.2478/AMB-2023-0031Keywords:
chronic pulmonary aspergillosis, COVID-19, surgeryAbstract
Aspergillosis is a fungal infection, caused by the mould Aspergillus, most commonly Aspergillus fumigatus species. Chronic pulmonary aspergillosis after SARS Cov-2 infection is a rare presentation that is commonly misdiagnosed. The prolonged corticosteroid and antibiotic application and the pro-infl ammatory state in COVID-19 patients predisposes to Aspergillus infection and its chronifi cation. Surgery plays a pivotal role in cases with unclear diagnosis, ineff ective medical therapy or when complications develop. We present a case of a 73-year-old woman with chronic pulmonary aspergillosis, developed after COVID-19 pneumonia. A right lateral muscle-sparing thoracotomy, right upper lobectomy and atypical resection of the 9th and 10th segments were performed.
References
Razafi ndrasoa ZA, Ravahatra K, Tiaray HM, et al. COVID-19 complicated with chronic necrotizing pulmonary aspergillosis and aspergilloma progressing to fi brosing aspergillosis: A case report. Clin Case Rep. 2022;10(5):e05814. Published 2022 May 5. doi: 10.1002/ccr3.5814.
Hayes GE, Novak-Frazer L. Chronic pulmonary Aspergillosis-Where are we? and Where are we going? J Fungi (Basel). 2016;2(2):18. Published 2016 Jun 7. doi: 10.3390/jof2020018.
Gaillard F, Theckumparampil N, Jones J, et al. Subacute invasive pulmonary aspergillosis. Reference article, Radiopaedia.org (Accessed on 04 Jan 2023) https://doi.org/10.53347/rID-8696.
Akram W, Ejaz MB, Mallhi TH, et al. Clinical manifestations, associated risk factors and treatment outcomes of Chronic Pulmonary Aspergillosis (CPA): Experiences from a tertiary care hospital in Lahore, Pakistan. PLoS One. 2021;16(11):e0259766. Published 2021 Nov 12. doi: 10.1371/journal.pone.0259766.
Maghrabi F, Denning DW. The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach. Curr Fungal Infect Rep. 2017;11(4):242-251. doi: 10.1007/s12281-017-0304-7.
Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1-e60. doi: 10.1093/cid/ciw326.
Farid S, Mohamed S, Devbhandari M, et al. Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence – a National Centre’s experience. J Cardiothorac Surg. 2013;8:180. Published 2013 Aug 5. doi: 10.1186/1749-8090-8-180.
Setianingrum F, Rozaliyani A, Adawiyah R, et al. A prospective longitudinal study of chronic pulmonary aspergillosis in pulmonary tuberculosis in Indonesia (APICAL). Thorax. 2022;77(8):821-828. doi: 10.1136/thoraxjnl-2020-216464.
Rouzé A, Martin-Loeches I, Nseir S. COVID-19-associated pulmonary aspergillosis: an underdiagnosed or overtreated infection?. Curr Opin Crit Care. 2022;28(5):470-479. doi: 10.1097/MCC.0000000000000977.
Denning DW, Page ID, Chakaya J, et al. Case defi nition of chronic pulmonary aspergillosis in resource-constrained settings. Emerg Infect Dis. 2018;24(8):e171312. doi: 10.3201/eid2408.171312.
Bongomin F, Harris C, Hayes G, et al. Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis. PLoS One. 2018;13(4):e0193732. Published 2018 Apr 10. doi: 10.1371/journal.pone.0193732.
Patel DC, Bhandari P, Epstein DJ, et al. Surgical resection for patients with pulmonary aspergillosis in the national inpatient sample. J Thorac Dis. 2021;13(8):4977-4987. doi: 10.21037/jtd-21-151.
Shen C, Qiao G, Wang C, et al. Outcomes of surgery for different types of chronic pulmonary aspergillosis: results from a single-center, retrospective cohort study. BMC Pulm Med. 2022;22(1):40. Published 2022 Jan 19. doi: 10.1186/s12890-022-01836-z.
Ullmann AA, Aguado J Arikan-Akdagli S, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24 Suppl(1):1-38.
Al-Shair K, Atherton GT, Harris C, et al. Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis. Clin Infect Dis. 2013;57(6):828-835. doi: 10.1093/cid/cit411.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.
Journal Acta Medica Bulgarica 
